Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Bullboard Posts
Comment by Joseph_Kon Apr 07, 2017 9:26am
264 Views
Post# 26090548

RE:RE:Was today's NR good or bad news?

RE:RE:Was today's NR good or bad news?
digitel wrote: I don't think the lowest sales in seven quarters is good news, nor the marginal profit of $127,000 in Q4. That's two weak quarters in a row and given they still don't have the new plant up and running are we in store for 2 more transition quarters and the risk of delays?


Agreed.   It sure looked like bad news to me.  

December 2nd, 2016, Fabrice goes on Market Call and tells us it is trading at about 12x earnings and makes it a top pick.    It was trading at $1.42 at that time.

What is the P/E ratio today?  What would the stock price be if we were actually trading at about 12x earnings now?   60 cents?

This was a setback.  No question about it.   That said, there is a ton of potential here, down the road a ways.

Bullboard Posts